- Associated Press•14 days ago
On a per-share basis, the San Diego-based company said it had a loss of 35 cents. The pharmaceutical and drug compounding company posted revenue of $4.9 million in the period. In the final minutes of trading ...
- PR Newswire•14 days ago
SAN DIEGO, Aug. 15, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company dedicated to making drugs affordable again through its Branded Compounding™ business model, ...
- Accesswire•15 days agoInvestor Calendar Invites You to the Imprimis Pharmaceuticals Second Quarter 2016 Earnings Conference Call and Webcast Live on Monday, August 15, 2016
SAN DIEGO, CA / ACCESSWIRE / August 15, 2016 / Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held Monday, ...
Imprimis Pharmaceuticals, Inc. (IMMY)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||3.55 x 200|
|Day's Range||3.77 - 3.92|
|52wk Range||3.34 - 8.79|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-2.31|
|Avg Vol (3m)||30,329|
|Dividend & Yield||N/A (N/A)|